Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares 7-10 Year Treasury Bond ETF (IEF) vs Koninklijke Philips NV (PHG) Price & Performance

iShares 7-10 Year Treasury Bond ETFTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

iShares 7-10 Year Treasury Bond ETF vs Koninklijke Philips NV — how do they compare? iShares 7-10 Year Treasury Bond ETF trades at $92.9, while Koninklijke Philips NV trades at $27.09 (market cap $26.33B). The key difference: Koninklijke Philips NV pays a 3.76% dividend while iShares 7-10 Year Treasury Bond ETF pays none, and Koninklijke Philips NV is trading nearer its 52-week high, iShares 7-10 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.

IEFPHG
52-Week High
$97.99$32.91
52-Week Low
$92.76$25.02
Market Cap
$26.33B
Sector
Health
Enterprise Value
$32.89B
Dividend Yield
3.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares 7-10 Year Treasury Bond ETF

IEF (iShares 7-10 Year Treasury Bond ETF) trades at $93.17 with minimal daily movement (+0.24%). Technical indicators show a neutral to bearish bias with moving averages signaling caution. The ETF maintains consistent dividend distributions, with recent payments of $0.31-$0.32 per share. Market focus remains on Treasury yield movements influenced by inflation data and Middle East tensions affecting oil prices.

Outlook remains tied to interest rate expectations and inflation trends. Recent institutional accumulation by Bank of America and Ferguson Shapiro provides support, but rising Treasury yields pose headwinds. Key risks include Federal Reserve policy shifts and geopolitical volatility impacting bond markets.

Koninklijke Philips NV

PHG trades at $26.73, up 1.52% today, with a bullish technical signal and recent earnings beats in Q4 2025, Q1 2026, and Q2 2026. The company reported $17.83B revenue and $895M net income for 2025, with a P/E of 20.29 and net margin of 6.31%. Recent news highlights Exor increasing its stake and FDA clearances for new health tech products, supporting positive sentiment.

Outlook is cautiously optimistic with strong profitability and institutional interest, but risks include order intake volatility and debt levels. Analysts show 40.9% buy ratings, indicating potential upside if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares 7-10 Year Treasury Bond ETF

The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.

Read more on IEF

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG